Microbot Medical Inc. (MBOT)
NCM · Medical Instruments & Supplies
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Peers in Medical Instruments & Supplies
All in industry →Intuitive Surgical, Inc.
Medline Inc.
Becton, Dickinson and Company
Alcon Inc.
ResMed Inc.
West Pharmaceutical Services, Inc.
The Cooper Companies, Inc.
Align Technology, Inc.
Solventum Corporation
Baxter International Inc.
Recent press releases
April 2026
MBOT Launches $39.2M ATM Offering to Fund LIBERTY Development
# 🔎 What This Document Is This is a **prospectus supplement** for an "at-the-market" (ATM) offering. Think of it as a detailed menu for selling stock directly into the market. Microbot Medical can now sell up to **$39,230,691** of its common stock through the investment bank H.C. Wainwright, acting
SEC filings
All filings →Insider trades
All insider trades →Microbot Medical Inc. has no reported insider trades in the last 90 days.